{"id":"https://openalex.org/W7225317757","doi":"https://doi.org/10.1007/s00277-026-07347-9","title":"Durable remission for more than 5 years with gilteritinib in FLT3-ITD-positive acute myeloid leukemia relapsing after a second allogeneic transplantation","display_name":"Durable remission for more than 5 years with gilteritinib in FLT3-ITD-positive acute myeloid leukemia relapsing after a second allogeneic transplantation","publication_year":2026,"publication_date":"2026-11-06","ids":{"openalex":"https://openalex.org/W7225317757","doi":"https://doi.org/10.1007/s00277-026-07347-9"},"language":"en","primary_location":{"id":"doi:10.1007/s00277-026-07347-9","doi":"https://doi.org/10.1007/s00277-026-07347-9","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00277-026-07347-9","pdf_url":null,"source":{"id":"https://openalex.org/S163204731","display_name":"Annals of Hematology","issn_l":"0939-5555","issn":["0939-5555","1432-0584"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Hematology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1007/s00277-026-07347-9","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019513106","display_name":"Seiichiro Katagiri","orcid":"https://orcid.org/0000-0002-3031-9990","observed_orcids":["https://orcid.org/0000-0002-3031-9990"]},"institutions":[{"id":"https://openalex.org/I158929114","display_name":"Tokyo Medical University","ror":"https://ror.org/00k5j5c86","country_code":"JP","type":"education","lineage":["https://openalex.org/I158929114"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Seiichiro Katagiri","raw_affiliation_strings":["Department of Hematology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan"],"raw_orcid":"https://orcid.org/0000-0002-3031-9990","affiliations":[{"raw_affiliation_string":"Department of Hematology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan","institution_ids":["https://openalex.org/I158929114"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067797610","display_name":"Mitsuru Moriyama","orcid":"https://orcid.org/0000-0003-2105-1432","observed_orcids":["https://orcid.org/0000-0003-2105-1432"]},"institutions":[{"id":"https://openalex.org/I158929114","display_name":"Tokyo Medical University","ror":"https://ror.org/00k5j5c86","country_code":"JP","type":"education","lineage":["https://openalex.org/I158929114"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mitsuru Moriyama","raw_affiliation_strings":["Department of Hematology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan","institution_ids":["https://openalex.org/I158929114"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111555297","display_name":"Seiichiro Yoshizawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I158929114","display_name":"Tokyo Medical University","ror":"https://ror.org/00k5j5c86","country_code":"JP","type":"education","lineage":["https://openalex.org/I158929114"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Seiichiro Yoshizawa","raw_affiliation_strings":["Department of Hematology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan","institution_ids":["https://openalex.org/I158929114"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089308854","display_name":"SungGi Chi","orcid":"https://orcid.org/0000-0002-5725-7187","observed_orcids":["https://orcid.org/0000-0002-5725-7187"]},"institutions":[{"id":"https://openalex.org/I4210145079","display_name":"National Cancer Center Hospital East","ror":"https://ror.org/03rm3gk43","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210145079"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"SungGi Chi","raw_affiliation_strings":["Department of Hematology, National Cancer Center Hospital East, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, National Cancer Center Hospital East, Chiba, Japan","institution_ids":["https://openalex.org/I4210145079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069675532","display_name":"Yosuke Minami","orcid":"https://orcid.org/0000-0003-0863-0739","observed_orcids":["https://orcid.org/0000-0003-0863-0739"]},"institutions":[{"id":"https://openalex.org/I4210145079","display_name":"National Cancer Center Hospital East","ror":"https://ror.org/03rm3gk43","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210145079"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yosuke Minami","raw_affiliation_strings":["Department of Hematology, National Cancer Center Hospital East, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, National Cancer Center Hospital East, Chiba, Japan","institution_ids":["https://openalex.org/I4210145079"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002320368","display_name":"Daigo Akahane","orcid":"https://orcid.org/0000-0002-9295-1465","observed_orcids":["https://orcid.org/0000-0002-9295-1465"]},"institutions":[{"id":"https://openalex.org/I158929114","display_name":"Tokyo Medical University","ror":"https://ror.org/00k5j5c86","country_code":"JP","type":"education","lineage":["https://openalex.org/I158929114"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Daigo Akahane","raw_affiliation_strings":["Department of Hematology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan","institution_ids":["https://openalex.org/I158929114"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5019513106"],"corresponding_institution_ids":["https://openalex.org/I158929114"],"apc_list":{"value":4590,"currency":"USD","value_usd":4590},"apc_paid":{"value":4590,"currency":"USD","value_usd":4590},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gilteritinib","display_name":"gilteritinib","score":0.9470000267028809},{"id":"https://openalex.org/keywords/flt3-itd-mutation","display_name":"FLT3-ITD","score":0.9670000076293945},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9089999794960022},{"id":"https://openalex.org/keywords/quizartinib","display_name":"quizartinib","score":0.9150000214576721},{"id":"https://openalex.org/keywords/second-allogeneic-hematopoietic-stem-cell-transplantation","display_name":"second allogeneic hematopoietic stem cell transplantation","score":0.8859999775886536},{"id":"https://openalex.org/keywords/cord-blood-transplantation","display_name":"cord blood transplantation","score":0.9380000233650208},{"id":"https://openalex.org/keywords/npm1-mutation","display_name":"NPM1 mutation","score":0.9350000023841858},{"id":"https://openalex.org/keywords/long-term-remission","display_name":"long-term remission","score":0.7409999966621399},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.4129999876022339},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.6610000133514404}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.885699987411499},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.7186999917030334},{"id":"https://openalex.org/C194409129","wikidata":"https://www.wikidata.org/wiki/Q103824","display_name":"Hematology","level":2,"score":0.6930999755859375},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6054999828338623},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.5443000197410583},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49540001153945923},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.39320001006126404},{"id":"https://openalex.org/C3018657049","wikidata":"https://www.wikidata.org/wiki/Q1595418","display_name":"Complete remission","level":3,"score":0.38449999690055847},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.3582000136375427},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.290800005197525},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2904999852180481},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.27309998869895935},{"id":"https://openalex.org/C2993713153","wikidata":"https://www.wikidata.org/wiki/Q211709","display_name":"Hematopoietic cell","level":4,"score":0.27090001106262207},{"id":"https://openalex.org/C2994180119","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Bone marrow transplantation","level":3,"score":0.25189998745918274}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1007/s00277-026-07347-9","doi":"https://doi.org/10.1007/s00277-026-07347-9","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00277-026-07347-9","pdf_url":null,"source":{"id":"https://openalex.org/S163204731","display_name":"Annals of Hematology","issn_l":"0939-5555","issn":["0939-5555","1432-0584"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Hematology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1007/s00277-026-07347-9","doi":"https://doi.org/10.1007/s00277-026-07347-9","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00277-026-07347-9","pdf_url":null,"source":{"id":"https://openalex.org/S163204731","display_name":"Annals of Hematology","issn_l":"0939-5555","issn":["0939-5555","1432-0584"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Hematology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4313255022","https://openalex.org/W7154746688","https://openalex.org/W3098579814","https://openalex.org/W3012461044","https://openalex.org/W4288046903","https://openalex.org/W4405051359","https://openalex.org/W4406364875","https://openalex.org/W4400262926","https://openalex.org/W2891324443","https://openalex.org/W6939670842"],"abstract_inverted_index":{"Acquired":[0],"resistance":[1],"to":[2,84,92],"FLT3":[3,10,27,72,77,85,106,171],"inhibitors":[4],"remains":[5],"a":[6,18,39,88],"major":[7],"challenge":[8],"in":[9,82,134,156],"-mutated":[11,23],"acute":[12],"myeloid":[13],"leukemia":[14],"(AML).":[15],"We":[16],"report":[17,98],"44-year-old":[19],"man":[20],"with":[21],"NPM1":[22],"AML":[24],"who":[25],"developed":[26],"-ITD":[28],"at":[29,123],"hematological":[30],"relapse":[31,58,124],"after":[32,65],"cord":[33],"blood":[34],"transplantation.":[35,68],"The":[36,69,94],"patient":[37,153],"underwent":[38],"second":[40,67,120],"allogeneic":[41],"hematopoietic":[42],"stem":[43],"cell":[44],"transplantation":[45],"while":[46],"receiving":[47],"quizartinib":[48,55,91,116,126],"as":[49,105],"salvage":[50],"therapy,":[51],"followed":[52],"by":[53],"post-transplant":[54],"maintenance.":[56],"Hematological":[57],"occurred":[59],"during":[60,125],"maintenance":[61,127],"approximately":[62],"3":[63],"months":[64],"the":[66,100,119,135,152,166],"LeukoStrat":[70],"CDx":[71],"Mutation":[73],"Assay":[74],"detected":[75,133],"an":[76],"tyrosine":[78,101],"kinase":[79,102],"domain":[80,103],"mutation":[81],"addition":[83],"-ITD,":[86],"prompting":[87],"switch":[89],"from":[90,112],"gilteritinib.":[93],"subsequent":[95],"FoundationOne":[96],"Heme":[97],"characterized":[99],"alteration":[104],"-D835V.":[107],"Retrospective":[108],"comparison":[109,178],"of":[110,169,179],"results":[111],"specimens":[113],"collected":[114],"before":[115,118],"initiation,":[117],"transplantation,":[121],"and":[122,151,176],"showed":[128],"that":[129],"D835V":[130],"was":[131],"not":[132],"two":[136],"earlier":[137],"specimens.":[138],"Gilteritinib":[139],"induced":[140],"complete":[141],"remission":[142,157],"without":[143],"additional":[144],"intensive":[145],"chemotherapy":[146],"or":[147],"donor":[148],"lymphocyte":[149],"infusion,":[150],"has":[154],"remained":[155],"for":[158,173,183],"more":[159],"than":[160],"5":[161],"years.":[162],"This":[163],"case":[164],"illustrates":[165],"complementary":[167],"value":[168],"clinical":[170],"testing":[172],"treatment":[174],"selection":[175],"retrospective":[177],"serial":[180],"genomic":[181],"findings":[182],"characterizing":[184],"relapse.":[185]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-06T00:00:00"}